{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:14:45Z","timestamp":1788984885447,"version":"build-2803163510"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0236156","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T17:57:10Z","timestamp":1597687030000},"page":"e0236156","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-6897","authenticated-orcid":true,"given":"Sam","family":"Miti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Handema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Mulenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan K.","family":"Mwansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Frimpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia M.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangani","family":"Zulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mpanji","family":"Siwingwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mwakazanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Kalibala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Denison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"pone.0236156.ref001","author":"R Marcus","year":"2017"},{"key":"pone.0236156.ref002","volume-title":"Ministry of Health-HMIS 2018.","author":"MOH-Zambia","year":"2019"},{"key":"pone.0236156.ref003","author":"R Boerma","year":"2017","journal-title":"Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure"},{"issue":"10","key":"pone.0236156.ref004","doi-asserted-by":"crossref","first-page":"e0186619","DOI":"10.1371\/journal.pone.0186619","article-title":"Upward trends of acquired drug resistances in Ethiopian HIV-1C isolates: A decade longitudinal study","volume":"12","author":"A Mulu","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"pone.0236156.ref005","doi-asserted-by":"crossref","first-page":"e0205446","DOI":"10.1371\/journal.pone.0205446","article-title":"HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003\u20132013","volume":"13","author":"DA Arimide","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"pone.0236156.ref006","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/jac\/dkx188","article-title":"Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children","volume":"72","author":"C Kityo","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"pone.0236156.ref007","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/088922203762688667","article-title":"Prevalence of Drug-Resistance-Associated Mutations in Antiretroviral Drug-Naive Zambians Infected with Subtype C HIV-1","volume":"19","author":"R Handema","year":"2003","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"1","key":"pone.0236156.ref008","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/QAI.0b013e3181e544e0","article-title":"HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia","volume":"55","author":"RL Hamers","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"pone.0236156.ref009","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/jmv.24162","article-title":"Characterization of HIV Drug Resistance Mutations Among Patients Failing First-Line Antiretroviral Therapy From a Tertiary Referral Center in Lusaka, Zambia","volume":"87","author":"L Seu","year":"2015","journal-title":"Journal of medical virology"},{"issue":"13","key":"pone.0236156.ref010","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1097\/QAD.0000000000001569","article-title":"HIV drug resistance in infants increases with changing prevention of mother-to-child transmission regimens","volume":"31","author":"L.K. C-LC Poppe","year":"2017","journal-title":"AIDS"},{"issue":"1","key":"pone.0236156.ref011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/QAD.0000000000001273","article-title":"Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern","volume":"31","author":"L Muri","year":"2017","journal-title":"AIDS"},{"key":"pone.0236156.ref012","author":"S Inzaule","year":"2017","journal-title":"When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children"},{"key":"pone.0236156.ref013","author":"A H Sohn","year":"2013","journal-title":"The changing epidemiology of the global paediatric HIV epidemic: Keeping track of perinatally HIV-infected adolescents"},{"issue":"9","key":"pone.0236156.ref014","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s10461-016-1534-3","article-title":"Psychological Stressors and Coping Strategies Used by Adolescents Living with and Not Living with Hiv Infection in Nigeria","volume":"21","author":"MO Folayan","year":"2017","journal-title":"AIDS and Behavior"},{"issue":"12","key":"pone.0236156.ref015","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1080\/17441692.2016.1170871","article-title":"Psychological distress among Ugandan adolescents living with HIV: Examining stressors and the buffering role of general and religious coping strategies","volume":"12","author":"M Mutumba","year":"2017","journal-title":"Global Public Health"},{"issue":"5","key":"pone.0236156.ref016","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/09540121.2018.1425364","article-title":"Psychological well-being and adherence to antiretroviral therapy among adolescents living with HIV","volume":"30","author":"S Okawa","year":"2018","journal-title":"Zambia. AIDS Care"},{"issue":"6","key":"pone.0236156.ref017","doi-asserted-by":"crossref","first-page":"e0198802","DOI":"10.1371\/journal.pone.0198802","article-title":"Pediatric to adult healthcare transitioning for adolescents living with HIV in Nigeria: A national survey","volume":"13","author":"OA Badejo","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"pone.0236156.ref018","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1054-139X(01)00341-X","article-title":"From adolescence through young adulthood: Psychosocial adjustment associated with long-term survival of HIV","volume":"30","author":"HB Battles","year":"2002","journal-title":"Journal of Adolescent Health"},{"issue":"2","key":"pone.0236156.ref019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-3099(02)00183-4","article-title":"Efficacy of highly active antiretroviral therapy in HIV-1 infected children","volume":"2","author":"AMC van Rossum","year":"2002","journal-title":"The Lancet Infectious Diseases"},{"key":"pone.0236156.ref020","unstructured":"Ministry of Health Z. Zambia Population-based HIV Impact Assessment (ZAMPHIA) 2016: Final Report. Lusaka2019."},{"key":"pone.0236156.ref021","volume-title":"Zambia Population-based HIV Impact Assessment (ZAMPHIA) 2016: Final Report","author":"Ministry of Health Z","year":"2019"},{"key":"pone.0236156.ref022","unstructured":"Sam M, editor Prevalence of Treatment failure at ADCH, Ndola 11th Annual National HIV Technical Conference: \u201cfast- tracking Towards HIV Epidemic Control while Maintaining Quality Health Care\u201d; 2017 13\u201314 December 2017; Lusaka."},{"key":"pone.0236156.ref023","article-title":"Project YES! Youth Engaging for Success: A randomized controlled trial assessing the impact of a clinic-based youth peer mentoring program on viral load status, adherence and internalized stigma among HIV-positive youth (15\u201324 years) in Ndola, Zambia","author":"BV Denison J","year":"2018"},{"issue":"1","key":"pone.0236156.ref024","doi-asserted-by":"crossref","first-page":"e14638","DOI":"10.1371\/journal.pone.0014638","article-title":"Differences in reversion of resistance mutations to wild-type under structured treatment interruption and related increase in replication capacity","volume":"6","author":"AC Paquet","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"pone.0236156.ref025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3851\/IMP2746","article-title":"Resistance TAStE. The impact of wild-type reversion on transmitted resistance surveillance","volume":"19","author":"DC Boettiger","year":"2014","journal-title":"Antivir Ther"},{"key":"pone.0236156.ref026","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-017-0161-z","article-title":"High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa","author":"E Etta","year":"2017"},{"issue":"1","key":"pone.0236156.ref027","doi-asserted-by":"crossref","first-page":"20683","DOI":"10.7448\/IAS.19.1.20683","article-title":"High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo","volume":"19","author":"M Salou","year":"2016","journal-title":"Journal of the International AIDS Society"},{"key":"pone.0236156.ref028","author":"Z Ministry of Health","year":"2018","journal-title":"Zambia Consolidated Guidelines for HIV Treatment and Prevention 2018"},{"key":"pone.0236156.ref029","author":"R Hamers","year":"2010","journal-title":"HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia"},{"issue":"1","key":"pone.0236156.ref030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/infdis\/jiv008","article-title":"Interplay Between Transmitted and Acquired HIV Type 1 Drug Resistance: Reasons for a Disconnect","volume":"212","author":"A De Luca","year":"2015","journal-title":"J Infect Dis"},{"key":"pone.0236156.ref031","unstructured":"Michael Aboud RK, Johannes Lombaard,Fujie Zhang,Jos\u00e9 A Hidalgo,Elmira Mamedova,Marcelo H Losso,Ploenchan Chetchotisakd,Carlos Brites,J\u00f6rg Sievers,Dannae Brown,Judy Hopking,Mark Underwood,Maria Claudia Nascimento,Yogesh Punekar et al. Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial. The Lancet Infectious Diseases. March 2019 (https:\/\/doi.org\/10.1016\/S1473-3099(19)30036-2)."},{"issue":"1","key":"pone.0236156.ref032","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12977-018-0420-7","article-title":"Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants","volume":"15","author":"SJ Smith","year":"2018","journal-title":"Retrovirology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T17:58:17Z","timestamp":1597687097000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236156"}},"subtitle":[],"editor":[{"given":"Matt A.","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0236156","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]}}}